Embryonal Rhabdomyosarcoma: A Case Report

Mahbub, Muntasir; Mannan, Nabila; Shaheen, Mazharul; Chakraborti, Manash Ranjan; Shaifuddin, Akm; Kabir, Shahjahan; Murshed, KM Mamun; Hassan, Mahmudul; Ahmed, Khalil

doi:10.3329/bjo.v21i2.27654

Cited by 1 publication

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Soft tissue sarcoma of the head and neck in an adult patient is very rare with only several cases reported in literature [1,2,[6][7][8][9][10]. RMS is a rare and aggressive malignancy first described in 1854 by Weber and colleagues possibly originating from primitive mesenchymal cells that arise anywhere in the body, including sites where striate muscle is not found like nasal cavity and paranasal sinuses which represent only 10% of soft tissue sarcomas and less than 1% of malignant nasosinusal tumors in adults [11,12].…”

Section: Discussionmentioning

confidence: 99%

“…Rhabdomyosarcoma is a rare soft tissue malignancy derived from myogenic cells. It represents the most common soft tissue sarcoma of childhood and adolescence and the most common pediatric soft tissue neoplasm affecting the nasal cavity and paranasal sinuses [1]. On the other hand, it is unusual in adults, represented only 10% of soft tissue sarcomas and less than 1% of malignant nasosinusal tumors [2].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Minimally Invasive Approach for Orbital and Parameningeal Rhabdomyosarcoma

Giol-Alvarez¹,

Aparicio-García²,

Gamez-Pérez³

et al. 2018

Case Report: Unusual Splenic Mass in an Elderly Patient

View full text Add to dashboard Cite

Rhabdomyosarcoma is a rare soft tissue malignancy derived from myogenic cells. There is very little literature that provides substantial evidence regarding the outcomes of surgical treatment of parameningeal subtype. Endonasal endoscopic resection offers a faster recovery with minimal morbidity, providing a better life quality and immediately adjuvant treatment. Minimally invasive pericranial flap constitute a good alternative in cases with non-viable mucosal vascularized nasoseptal flap. Multimodal treatment ae essential.

show abstract